Multiple Hypercoagulability Disorders at Presentation of Non-Small-Cell Lung Cancer |
Lee, Jeong Min
(Department of Internal Medicine, Inha University College of Medicine)
Lim, Jun Hyeok (Department of Internal Medicine, Inha University College of Medicine) Kim, Jung-Soo (Department of Internal Medicine, Inha University College of Medicine) Park, Ji Sun (Department of Internal Medicine, Inha University College of Medicine) Memon, Azra (Department of Internal Medicine, Inha University College of Medicine) Lee, Seul-Ki (Department of Internal Medicine, Inha University College of Medicine) Nam, Hae-Seong (Department of Internal Medicine, Inha University College of Medicine) Cho, Jae-Hwa (Department of Internal Medicine, Inha University College of Medicine) Kwak, Seung-Min (Department of Internal Medicine, Inha University College of Medicine) Lee, Hong Lyeol (Department of Internal Medicine, Inha University College of Medicine) Kim, Hyun-Jung (Department of Internal Medicine, Inha University College of Medicine) Hong, Geun-Jeong (Department of Internal Medicine, Inha University College of Medicine) Ryu, Jeong-Seon (Department of Internal Medicine, Inha University College of Medicine) |
1 | Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846-50. DOI ScienceOn |
2 | Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002;4:465-73. DOI ScienceOn |
3 | Connolly GC, Dalal M, Lin J, Khorana AA. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer. Lung Cancer 2012;78:253-8. DOI |
4 | Young A, Chapman O, Connor C, Poole C, Rose P, Kakkar AK. Thrombosis and cancer. Nat Rev Clin Oncol 2012;9:437-49. DOI |
5 | Falanga A, Ofosu FA, Delaini F, Oldani E, Dewar L, Lui L, et al. The hypercoagulable state in cancer patients: evidence for impaired thrombin inhibitions. Blood Coagul Fibrinolysis 1994;5 Suppl 1:S19-23. |
6 | Glassman AB. Hemostatic abnormalities associated with cancer and its therapy. Ann Clin Lab Sci 1997;27:391-5. |
7 | Falanga A, Rickles FR. Pathophysiology of the thrombophilic state in the cancer patient. Semin Thromb Hemost 1999;25:173-82. DOI |
8 | Gross L, Friedberg CK. Nonbacterial thrombotic endocarditis: classification and general description. Arch Intern Med 1936;58:620-40. DOI |
9 | el-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment. Oncologist 2007;12:518-23. DOI ScienceOn |
10 | Lopez JA, Ross RS, Fishbein MC, Siegel RJ. Nonbacterial thrombotic endocarditis: a review. Am Heart J 1987;113:773-84. DOI |
11 | Borowski A, Ghodsizad A, Cohnen M, Gams E. Recurrent embolism in the course of marantic endocarditis. Ann Thorac Surg 2005;79:2145-7. DOI |
12 | Chino F, Kodama A, Otake M, Dock DS. Nonbacterial thrombotic endocarditis in a Japanese autopsy sample: a review of eighty cases. Am Heart J 1975;90:190-8. DOI |
13 | Taniyama D, Yamamoto R, Kawasaki M, Kamata H, Miyamoto K, Mashimo S, et al. Nonbacterial thrombotic endocarditis leading to acute heart failure due to aortic stenosis in a patient with lung cancer. Intern Med 2013;52:1617-20. DOI |
14 | Dipasco PJ, Misra S, Koniaris LG, Moffat FL Jr. Thrombophilic state in cancer, part I: biology, incidence, and risk factors. J Surg Oncol 2011;104:316-22. DOI |